• Home
  • About Us
  • Parametric Insurance
  • Your Voice Matters
  • Contact Us
  • More
    • Home
    • About Us
    • Parametric Insurance
    • Your Voice Matters
    • Contact Us
  • Home
  • About Us
  • Parametric Insurance
  • Your Voice Matters
  • Contact Us

Welcome

INNOVATRIX CAPITAL

INNOVATRIX CAPITAL INNOVATRIX CAPITAL INNOVATRIX CAPITAL

Derisking Clinical Trials

About Us

Our mission is to derisk Clinical Trials in order to encourage vital global drug development. 


Our solutions are designed to provide downside risk protection for clinical trials by paying out in the event of failure.


Despite $55bn spent annually worldwide on Clinical Trials this is not enough to meet the demand for new drugs. 


Attracting sufficient investment for much needed drug development is a long standing challenge as it is high risk, expensive and low return.


Innovatrix was established to change this by acting as a bridge between the Life Sciences and Risk Capital markets.


Our suite of solutions offer downside risk protection through Parametric (model driven) or traditional Indemnity based insurance products for any registered Clinical Trial irrespective of Therapeutic Area, Geography or Phase.

Find out more

PARAMETRIC INSURANCE

Our Approach

Our Approach

Our Approach

Parametric (model drive) insurance is increasingly a mainstream insurance product for both sophisticated companies and investors. 


Our next generation parametric solution will offer robust resilience to life cycle variations in Life Sciences R&D.


Payouts triggered upon failure of early termination of a Clinical Trial due to missed pre agreed primary protocol endpoints. 

Our Solution

Our Approach

Our Approach

Transparent

Clear and straightforward policy wording and terms


Affordable

Competitive when compared to other risk mitigation mechanisms


Customised 

Tailored to client individual needs


Efficient

Claims payment made quickly


Our Process

Our Approach

Our Process

STEP 1

We design customised cover for our client based on predefined parameters and a pre agreed indemnity


Step 2

We monitor how the parameters evolve relative to the predetermined exposure framework


Step 3

If triggered, clients are notified and quickly indemnified


YOUR VOICE MATTERS

We need your input

 

We're seeking views on our groundbreaking solution to shield the Life Sciences sector

from the failure of a clinical trial by reimbursing the expenses incurred in a specific failed 

Clinical Trial phase.

By participating in our short survey you'll directly influence the development of our industry

changing product.

To access the survey click on this link  Innovatrix Survey 

enquiries

QASIM AKBAR

qasim@innovatrixcap.co.uk


+ 44 (0) 7429 023 596



PIERS CLARK

piers@innovatrixcap.co.uk


+ 44 (0) 7714 457 450


Copyright © 2024 Innovatrix Capital Limited - All Rights Reserved.


This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept